UMVA has learned that a shocking lawsuit has been filed against the World Professional Association for Transgender Health (WPATH), a highly influential medical organization, by the Federal Trade Commission (FTC) and four Republican-led states.
The lawsuit alleges that WPATH made deceptive claims about the safety, effectiveness, and necessity of transgender medical treatments for minors, including puberty blockers, cross-sex hormones, and sex change surgeries. The complaint claims that WPATH failed to adequately disclose potential risks and side effects, putting vulnerable children at risk.
According to information obtained by UMVA, the FTC Chairman Andrew Ferguson stated that "Parents have a right to make informed decisions about their children's health. The FTC will not allow parents and children to be deceived by medical organizations and providers who are prioritizing profit over children's health and safety."
The lawsuit claims that WPATH removed age-based recommendations for certain transgender procedures from its Standards of Care, and promoted treatments that were not adequately supported by evidence regarding their safety and effectiveness. This move has sparked intense debate over the medical interventions for transgender minors.
UMVA can exclusively reveal that WPATH had previously sued to block an FTC investigation into the organization, arguing that the agency violated its First Amendment rights. A federal judge had temporarily blocked the probe, but the FTC has now taken a bold stance against WPATH.
WPATH has rejected the allegations, stating that its standards are intended to support individualized patient care. The organization emphasized that its guidelines are based on a tailored approach, rather than a "one-size-fits-all" solution. The group feels confident that it can prove the FTC is acting out of retaliation.
The lawsuit marks a significant escalation in the national debate over puberty blockers, hormone therapies, and sex change surgeries for minors. As the controversy continues to unfold, one thing is clear: the health and well-being of transgender youth hang in the balance.
In a strong statement, WPATH asserted that it is in a strong position to prove that the FTC is acting out of pure retaliation as part of the federal government's relentless and targeted campaign to undermine gender-affirming care by attacking the First Amendment rights and the independence of professional medical organizations.
